Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1972 Jun;26(3):141–153. doi: 10.1038/bjc.1972.21

Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer.

G A Currie
PMCID: PMC2008476  PMID: 4114812

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander P., Delorme E. J., Hamilton L. D., Hall J. G. Effect of nucleic acids from immune lymphocytes on rat sarcomata. Nature. 1967 Feb 11;213(5076):569–572. doi: 10.1038/213569a0. [DOI] [PubMed] [Google Scholar]
  2. Andrews G. A., Congdon C. C., Edwards C. L., Gengozian N., Nelson B., Vodopick H. Preliminary trials of clinical immunotherapy. Cancer Res. 1967 Dec;27(12):2535–2541. [PubMed] [Google Scholar]
  3. BUINAUSKAS P., McCREDIE J. A., BROWN E. R., COLE W. H. Experimental treatment of tumors with antibodies. Arch Surg. 1959 Sep;79:432–437. doi: 10.1001/archsurg.1959.04320090080012. [DOI] [PubMed] [Google Scholar]
  4. Cunningham T. J., Olson K. B., Laffin R., Horton J., Sullivan J. Treatment of advanced cancer with active immunization. Cancer. 1969 Nov;24(5):932–937. doi: 10.1002/1097-0142(196911)24:5<932::aid-cncr2820240510>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  5. Currie G. A., Bagshawe K. D. Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase. Br J Cancer. 1969 Mar;23(1):141–149. doi: 10.1038/bjc.1969.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Currie G. A., Lejeune F., Fairley G. H. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J. 1971 May 8;2(5757):305–310. doi: 10.1136/bmj.2.5757.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DAY E. D., BARNES G. W., PLANINSEK J. A., PRESSMAN D. Improved methods for the purification of tumor-localizing antibodies. J Natl Cancer Inst. 1958 Jun;20(6):1123–1139. doi: 10.1093/jnci/20.6.1123. [DOI] [PubMed] [Google Scholar]
  8. FINNEY J. W., BYERS E. H., WILSON R. H. Studies in tumor autoimmunity. Cancer Res. 1960 Apr;20:351–356. [PubMed] [Google Scholar]
  9. Fridman W. H., Kourilsky F. M. Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia. Nature. 1969 Oct 18;224(5216):277–279. doi: 10.1038/224277a0. [DOI] [PubMed] [Google Scholar]
  10. Hughes L. E., Kearney R., Tully M. A study in clinical cancer immunotherapy. Cancer. 1970 Aug;26(2):269–278. doi: 10.1002/1097-0142(197008)26:2<269::aid-cncr2820260205>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  11. Humphrey L. J., Jewell W. R., Murray D. R., Griffen W. O., Jr Immunotherapy for the patient with cancer. Ann Surg. 1971 Jan;173(1):47–54. doi: 10.1097/00000658-197101000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hunter-Craig I., Newton K. A., Westbury G., Lacey B. W. Use of vaccinia virus in the treatment of metastatic malignant melanoma. Br Med J. 1970 May 30;2(5708):512–515. doi: 10.1136/bmj.2.5708.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ikonopisov R. L., Lewis M. G., Hunter-Craig I. D., Bodenham D. C., Phillips T. M., Cooling C. I., Proctor J., Fairley G. H., Alexander P. Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J. 1970 Jun 27;2(5712):752–754. doi: 10.1136/bmj.2.5712.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KALISS N. Immunological enhancement of tumor homografts in mice: a review. Cancer Res. 1958 Oct;18(9):992–1003. [PubMed] [Google Scholar]
  15. Klein G., Clifford P., Klein E., Stjernswärd J. Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A. 1966 Jun;55(6):1628–1635. doi: 10.1073/pnas.55.6.1628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Klein G. Tumor-specific transplantation antigens: G. H. A. Clowes memorial lecture. Cancer Res. 1968 Apr;28(4):625–635. [PubMed] [Google Scholar]
  17. Laszlo J., Buckley C. E., 3rd, Amos D. B. Infusion of isologous immune plasma in chronic lymphocytic leukemia. Blood. 1968 Jan;31(1):104–110. [PubMed] [Google Scholar]
  18. MATHE G., AMIEL J. L., SCHWARZENBERG L., CATTAN A., SCHNEIDER M., DEVRIES M. J., TUBIANA M., LALANNE C., BINET J. L., PAPIERNIK M. SUCCESSFUL ALLOGENIC BONE MARROW TRANSPLANTATION IN MAN: CHIMERISM, INDUCED SPECIFIC TOLERANCE AND POSSIBLE ANTI-LEUKEMIC EFFECTS. Blood. 1965 Feb;25:179–196. [PubMed] [Google Scholar]
  19. MURRAY G. Experiments in immunity in cancer. Can Med Assoc J. 1958 Aug 15;79(4):249–259. [PMC free article] [PubMed] [Google Scholar]
  20. Mathé G., Amiel J. L., Schwarzenberg L., Schneider M., Cattan A., Schlumberger J. R., Hayat M., De Vassal F. Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969 Apr 5;1(7597):697–699. doi: 10.1016/s0140-6736(69)92648-8. [DOI] [PubMed] [Google Scholar]
  21. Morton D. L., Malmgren R. A., Holmes E. C., Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968 Jul;64(1):233–240. [PubMed] [Google Scholar]
  22. Morton D., Eilber F. R., Malmgren R. A., Wood W. C. Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery. 1970 Jul;68(1):158–164. [PubMed] [Google Scholar]
  23. Nadler S. H., Moore G. E. Immunotherapy of malignant disease. Arch Surg. 1969 Sep;99(3):376–381. doi: 10.1001/archsurg.1969.01340150084016. [DOI] [PubMed] [Google Scholar]
  24. Old L. J., Boyse E. A. Specific antigens of tumors and leukemias of experimental animals. Med Clin North Am. 1966 May;50(3):901–912. doi: 10.1016/s0025-7125(16)33187-x. [DOI] [PubMed] [Google Scholar]
  25. SOUTHAM C. M. Applications of immunology to clinical cancer. Past attempts and future possibilities. Cancer Res. 1961 Oct;21:1302–1316. [PubMed] [Google Scholar]
  26. SOUTHAM C. M. Relationships of immunology to cancer: a review. Cancer Res. 1960 Apr;20:271–291. [PubMed] [Google Scholar]
  27. Schwarzenberg L., Mathé G., Schneider M., Amiel J. L., Cattan A., Schlumberger J. R. Attempted adoptive immunotherapy of acute leukaemia by leucocyte transfusions. Lancet. 1966 Aug 13;2(7459):365–368. doi: 10.1016/s0140-6736(66)92661-4. [DOI] [PubMed] [Google Scholar]
  28. Symes M. O., Riddell A. G., Immelman E. J., Terblanche J. Immunologically competent cells in the treatment of malignant disease. Lancet. 1968 May 18;1(7551):1054–1056. doi: 10.1016/s0140-6736(68)91410-4. [DOI] [PubMed] [Google Scholar]
  29. Trouillas P., Lapras C. L'immunothérapie cellulaire des glioblastomes cérébraux. A propos de deux résultats. J Med Lyon. 1969 Oct 5;50(172):1269–1291. [PubMed] [Google Scholar]
  30. WOODRUFF M. F., NOLAN B. PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLS. Lancet. 1963 Aug 31;2(7305):426–429. doi: 10.1016/s0140-6736(63)92171-8. [DOI] [PubMed] [Google Scholar]
  31. Watkins J. F., Chen L. Immunization of mice against Ehrlich ascites tumour using a hamster-Ehrlich ascites tumour hybrid cell line. Nature. 1969 Sep 6;223(5210):1018–1022. doi: 10.1038/2231018a0. [DOI] [PubMed] [Google Scholar]
  32. Wolf P. L., Vazquez J., Czajkowski N. P., Rosenblatt M. A new method of active immunisation to autologous human tumour tissue. Lancet. 1967 Oct 28;2(7522):905–909. doi: 10.1016/s0140-6736(67)90229-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES